Browsing by Author Tsimihodimos, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 44 to 63 of 74 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patientsBairaktari, E.; Elisaf, M. S.; Katsaraki, A.; Tsimihodimos, V.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
The hypertriglyceridaemic waist phenotype as a marker of the atherogenic lipoprotein profile in metabolic syndromeGazi, I.; Tsimihodimos, V.; Liamis, G.; Kostapanos, M.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolGazi, I. F.; Filippatos, T. D.; Tsimihodimos, V.; Saougos, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Hypouricemia in a patient with thyrotoxicosisTsimihodimos, V.; Kalaitzides, R.; Elisaf, M. S.24-Nov-2015-
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Milionis, H.; Bairaktari, E.; Tzallas, C.; Miltiadous, G.; Katsaraki, A.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Miltiadus, G.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndromeTsimihodimos, V.; Gazi, I.; Kalaitzidis, R.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Iron overload: An additional feature of the metabolic syndrome?Kalogirou, G.; Tsimihodimos, V.; Kalaitzidis, R.; Bairaktari, E.; Siamopoulos, K.; Elisaf, M. S.; Seferiadis, K.24-Nov-2015-
Is therapy with statins effective in patients with homozygous familial hypercholesterolaemiaElisaf, M. E.; Miltiadous, G.; Xenophontos, S.; Tsimihodimos, V.; Tselepis, A.; Cariolou, M.; Papathanasiou, A.; Goudevenos, I.24-Nov-2015-
LDL cholesterol estimation in patients with the metabolic syndromeGazi, I.; Tsimihodimos, V.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Lipoprotein glomerulopathyTsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemiaMiltiadous, G.; Tsimihodimos, V.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Lipoprotein-associated phospholipase A(2) activity is a marker of small, dense LDL particles in human plasmaGazi, I.; Lourida, E. S.; Filippatos, T.; Tsimihodimos, V.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-